EpskA21
EpskA21 is an inhibitor for PI3K/AKT signaling pathway, and inhibits the proliferation of cancer cells MCF-7, A549, MIA-PaCa-2, Panc-1 and HepG2, with IC50 of 1.3-7.24 μM. EpskA21 inhibits the cell migration, arrests the cell cycle at G2/M (MCF-7) and S (MIA-PaCa-2) phase, and induces apoptosis in MCF-7 and MIA-PaCa-2. EpskA21 causes the mitochondrial dysfunction[1].
Product Specifications
UNSPSC
12352005
Target
Akt; Apoptosis; PI3K
Type
Reference compound
Related Pathways
Apoptosis; PI3K/Akt/mTOR
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/epska21.html
Smiles
C=C1[C@H]2[C@@H](OC(/C=C/C3=CC=NC=C3)=O)[C@]4(C1=O)C([C@H]5[C@]6([H])C(C)(C)C(C=C[C@@]6(CO5)[C@]4([H])CC2)=O)=O
Molecular Formula
C28H27NO6
Molecular Weight
473.52
References & Citations
[1]Li H, et al., Design and synthesis of 6,20-epoxy A-ring modified oridonin derivatives with antitumor activity through extrinsic and mitochondrial pathways. Bioorg Chem. 2024 Jul 11;151:107632.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL704875V 500 µL Each
Tmem9b Rat shRNA Lentiviral Particle (Locus ID 293415)
Sign In for Pricing
View Details 
BT1502 1 Each
Orbi-Shaker™ MP with 4 position micro plate platform, 100-240V (US Plug)
Sign In for Pricing
View Details 
32060-05161 5x 30 µg
Human Annexin A7 (ANXA7) AssayLite™ Antibody (APC Conjugate)
Sign In for Pricing
View Details 